Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry.

Marin SJ, Metcalf A, Krasowski MD, Linert BS, Clark CJ, Strathmann FG, McMillin GA.

Ther Drug Monit. 2014 Feb;36(1):119-24. doi: 10.1097/FTD.0b013e3182a0d18c.

PMID:
24061447
2.

Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.

Montgomery DP, Plate CA, Jones M, Jones J, Rios R, Lambert DK, Schumtz N, Wiedmeier SE, Burnett J, Ail S, Brandel D, Maichuck G, Durham CA, Henry E, Christensen RD.

J Perinatol. 2008 Nov;28(11):750-3. doi: 10.1038/jp.2008.97. Epub 2008 Jul 3.

PMID:
18596707
3.

Detection of in utero marijuana exposure by GC-MS, ultra-sensitive ELISA and LC-TOF-MS using umbilical cord tissue.

Chittamma A, Marin SJ, Williams JA, Clark C, McMillin GA.

J Anal Toxicol. 2013 Sep;37(7):391-4. doi: 10.1093/jat/bkt052. Epub 2013 Jul 10.

PMID:
23843423
4.

Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.

Marin SJ, Keith L, Merrell M, McMillin GA.

J Anal Toxicol. 2009 Apr;33(3):148-54.

PMID:
19371463
5.

Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.

Concheiro M, González-Colmenero E, Lendoiro E, Concheiro-Guisán A, de Castro A, Cruz-Landeira A, López-Rivadulla M.

Ther Drug Monit. 2013 Aug;35(4):502-9. doi: 10.1097/FTD.0b013e31828a6148.

PMID:
23851907
6.

Broad-spectrum drug screening of meconium by liquid chromatography with tandem mass spectrometry and time-of-flight mass spectrometry.

Ristimaa J, Gergov M, Pelander A, Halmesmäki E, Ojanperä I.

Anal Bioanal Chem. 2010 Sep;398(2):925-35. doi: 10.1007/s00216-010-3942-y. Epub 2010 Jul 9.

PMID:
20617307
7.

Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium.

Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD.

J Perinatol. 2006 Jan 1;26(1):11-4.

PMID:
16281047
8.

Determination of drugs of abuse in meconium.

Moore C, Negrusz A, Lewis D.

J Chromatogr B Biomed Sci Appl. 1998 Aug 21;713(1):137-46. Review.

PMID:
9700556
9.

Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS)--toxicological findings in cases of alleged sexual assault.

Birkler RI, Telving R, Ingemann-Hansen O, Charles AV, Johannsen M, Andreasen MF.

Forensic Sci Int. 2012 Oct 10;222(1-3):154-61. doi: 10.1016/j.forsciint.2012.05.019. Epub 2012 Jul 6.

PMID:
22770621
10.

Development of a liquid chromatography-tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure.

Haglock-Adler CJ, McMillin GA, Strathmann FG.

Clin Biochem. 2016 Sep;49(13-14):1092-5. doi: 10.1016/j.clinbiochem.2016.04.007. Epub 2016 Apr 27.

PMID:
27131494
11.

Nicotine and metabolites in paired umbilical cord tissue and meconium specimens.

Marin SJ, Christensen RD, Baer VL, Clark CJ, McMillin GA.

Ther Drug Monit. 2011 Feb;33(1):80-5. doi: 10.1097/FTD.0b013e3182055f14.

PMID:
21192312
12.

Drugs of abuse detection in meconium: a comparison between ELISA and biochip microarray.

Marin SJ, Merrell M, McMillin GA.

J Anal Toxicol. 2011 Jan;35(1):40-5.

PMID:
21219702
13.

Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse.

Bar-Oz B, Klein J, Karaskov T, Koren G.

Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F98-F100.

14.

Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.

Marin SJ, Hughes JM, Lawlor BG, Clark CJ, McMillin GA.

J Anal Toxicol. 2012 Sep;36(7):477-86. doi: 10.1093/jat/bks061. Epub 2012 Jul 15.

PMID:
22802572
15.

An LC-MS-MS method for the comprehensive analysis of cocaine and cocaine metabolites in meconium.

Xia Y, Wang P, Bartlett MG, Solomon HM, Busch KL.

Anal Chem. 2000 Feb 15;72(4):764-71.

PMID:
10701261
16.

Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.

Saleh A, Stephanson NN, Granelli I, Villén T, Beck O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 15;909:6-13. doi: 10.1016/j.jchromb.2012.10.006. Epub 2012 Oct 9.

PMID:
23153637
17.

Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry.

Pelander A, Ristimaa J, Rasanen I, Vuori E, Ojanperä I.

Ther Drug Monit. 2008 Dec;30(6):717-24. doi: 10.1097/FTD.0b013e3181897cfa.

PMID:
18806694
18.

Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.

Lee Y, Lai KK, Sadrzadeh SM.

Clin Biochem. 2013 Aug;46(12):1118-24. doi: 10.1016/j.clinbiochem.2013.03.027. Epub 2013 Apr 11.

PMID:
23583348
19.

A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.

Wingert WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ.

J Forensic Sci. 1994 Jan;39(1):150-8.

PMID:
8113697
20.

Drugs of abuse in maternal hair and paired neonatal meconium: an objective assessment of foetal exposure to gestational consumption.

Joya X, Marchei E, Salat-Batlle J, García-Algar O, Calvaresi V, Pacifici R, Pichini S.

Drug Test Anal. 2016 Aug;8(8):864-8. doi: 10.1002/dta.1921. Epub 2015 Dec 2.

PMID:
26627903

Supplemental Content

Support Center